Beactica Therapeutics announces the selection of BEA-17 as a preclinical candidate ...Middle East

STOCKHOLM, Sept. 5, 2023 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision oncology company, today announced the selection of BEA-17 as a preclinical candidate for its LSD1 programme aimed at finding new therapies for aggressive brain tumours and other life-threatening...

Hence then, the article about beactica therapeutics announces the selection of bea 17 as a preclinical candidate was published today ( Tuesday 05/09/2023 - 08:57 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Beactica Therapeutics announces the selection of BEA-17 as a preclinical candidate )

Also on site :

• Cruise ship boss sues P&O for massive £9.7m over claims slip in toilet ended career
• '90s Alternative Rock Band Announces U.S. Tour Dates After Dropping New EP
• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Monday, January 19, 2026